Browsing by Keyword : Safety
Showing results 15 to 27 of 27
| Pub Year | | Title | Author(s) |
| 2014 | | Oral immunotherapy for the treatment of immediate type food allergy | 이수영 |
| 2021 | | Rapid symptom improvement in major depressive disorder using accelerated repetitive transcranial magnetic stimulation | 노재성, 손상준 |
| 2012 | | Roles of a hospital for community safety promotion | 이정아, 조준필 |
| 2019 | | Safety and Effectiveness Analysis of Kivexa(R) (lamivudine/abacavir sulfate) in Human Immunodeficiency Virus Infected Korean Patients | 최영화 |
| 2023 | | Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data | 서창희 |
| 2022 | | Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial | 손성연 |
| 2014 | | Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. | 오창권 |
| 2023 | | Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial | 박광주 |
| 2013 | | Safety and Reactogenicity of the Inactivated Poliomyelitis Vaccine (PoliorixTM) in Korea (2006-2012) | 박문성 |
| 2018 | | Safety and tolerability of Korean Red Ginseng in healthy adults: a multicenter, double-blind, randomized, placebo-controlled trial | 김광민 |
| 2024 | | Safety outcomes of antipsychotics classes in drug-naïve patients with first-episode schizophrenia: A nationwide cohort study in South Korea | 박래웅 |
| 2023 | | The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination | 최영화 |
| 2023 | | Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial | 최진혁 |
1
